Larry House
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Neutropenia and Cancer Infections
Papers in
-
- Cancer therapeutics and mechanisms 14
- PI3K/AKT/mTOR signaling in cancer 4
- Oncology 13
- Lung Cancer Research Studies 6
- Cancer Treatment and Pharmacology 4
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- Mark J. Ratain (27 shared papers)Jacqueline Ramı́rez (21 shared papers)Kehua Wu (8 shared papers)Yong Liu (2 shared papers)Samir D. Undevia (7 shared papers)Wanqing Liu (3 shared papers)Federico Innocenti (8 shared papers)Michael L. Maitland (6 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Clinical Cancer Research (3 papers)Clinical Pharmacology & Therapeutics (3 papers)European Journal of Cancer (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- United StatesChinaHong Kong
In The Last Decade
Larry House
28 papers receiving 593 citations
Peers
Comparison fields: 5 of 80
- Pharmacology 112
- Oncology 252
- Cancer Research 86
- Molecular Biology 330
- Pulmonary and Respiratory Medicine 112
Countries citing papers authored by Larry House
This map shows the geographic impact of Larry House's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry House with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry House more than expected).
Fields of papers citing papers by Larry House
This network shows the impact of papers produced by Larry House. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry House. The network helps show where Larry House may publish in the future.
Co-authors
The 25 scholars most cited alongside Larry House, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 105 | |
| 2 | 2009 | 90 | |
| 3 | 2008 | 54 | |
| 4 | 2012 | 54 | |
| 5 | 2012 | 51 | |
| 6 | 2011 | 38 | |
| 7 | 2010 | 36 | |
| 8 | 2013 | 28 | |
| 9 | 2010 | 22 | |
| 10 | 2011 | 20 | |
| 11 | 2007 | 18 | |
| 12 | 2015 | 12 | |
| 13 | 2014 | 11 | |
| 14 | 2021 | 10 | |
| 15 | 2015 | 8 | |
| 16 | 2019 | 8 | |
| 17 | 2011 | 6 | |
| 18 | 2022 | 6 | |
| 19 | 2007 | 6 | |
| 20 | 2013 | 5 |
About Larry House
Larry House is a scholar working on Molecular Biology, Oncology, Pharmacology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health, having authored 30 papers that have together received 604 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (14 papers), Pharmacogenetics and Drug Metabolism (12 papers), Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Treatment and Pharmacology (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Chemical Reactions and Isotopes (2 papers). The work is most often cited by research in Pharmacology (112 citations), Oncology (252 citations), Cancer Research (86 citations), Molecular Biology (330 citations) and Pulmonary and Respiratory Medicine (112 citations). Larry House has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Mark J. Ratain, Jacqueline Ramı́rez, Kehua Wu, Yong Liu, Samir D. Undevia, Wanqing Liu, Federico Innocenti, Michael L. Maitland, Linda Janisch and Theodore Karrison. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Clinical Pharmacology & Therapeutics, European Journal of Cancer and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.